plasma

An Associated Press investigation has found that the Trump administration awarded emergency coronavirus funds to a well-connected Republican donor’s company to test a possible COVID-19-fighting blood plasma technology.

The Food and Drug Administration has issued an emergency authorization for the use of convalescent plasma therapy in treating COVID-19. The move comes as the national death toll approaches 180,000.

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer. More than 64,000 patients in the U.S. have been given convalescent plasma, a century-old approach to fend off flu and measles before...

The Food and Drug Administration is reportedly nearing a decision to issue an emergency use authorization to use convalescent plasma for treating coronavirus patients. Unfortunately, the supply of plasma is running low.

An emergency room nurse in Riverside is struggling with COVID-19, and his wife is pleading with survivors of the virus to donate plasma because the antibodies could help save her husband’s life, along with the lives of others. “He comes home, locks himself in the garage while he takes all of his gear off,” Maria Fernandez, whose husband is...

Survivors of COVID-19 are donating their blood plasma in droves in hopes it helps other patients recover from the coronavirus. And while the jury’s still out, now scientists are testing if the donations might also prevent infection in the first place.

The most comprehensive national study to date has found that convalescent plasma appears to be safe to use on COVID-19 patients, a promising development in the race to find a treatment for the deadly virus. But the study didn’t determine whether the treatment works, NBC News reported. A team of more than 5,000 doctors from over 2,000 hospitals and laboratories…

Plasma is precious for people sick with COVID-19. The liquid portion of blood taken from survivors of the disease may be rich in antibodies that doctors hope can speed up recovery for the sickest patients.